Executive Brief: Competitive Landscape and Strategic Developments in the Middle EAST Anti Epileptic Drug Pediatrics Market
The Middle EAST Anti Epileptic Drug Pediatrics Market was valued at USD 0.45 billion in 2024 and is projected to reach USD 0.85 billion by 2034, registering a CAGR of 6.8%. This growth trajectory is underpinned by several factors, including the rising prevalence of epilepsy among children, increased awareness regarding pediatric epilepsy management, and advancements in drug formulations. The...
0 Commentaires 0 Parts 153 Vue 0 Aperçu